Katrine R. Schønnemann

Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer

Per Pfeiffer, Jakob Mortensen, Beth Bjerregaard et al. · European Journal of Cancer · 2006 · 82 citations

Medicine, Oncology, Pharmacology +15

Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients

Jon Kroll Bjerregaard, Michael Bau Mortensen, Katrine R. Schønnemann et al. · European Journal of Cancer · 2012 · 38 citations · Full text

Medicine, Oncology, Oncologic Surgery +11

Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancer

Katrine R. Schønnemann, M.K. Yilmaz, Jon Kroll Bjerregaard et al. · European Journal of Cancer · 2012 · 22 citations

Medicine, Oncology, Pharmacology +17

Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer

Katrine R. Schønnemann, Hanna Jensen, M.K. Yilmaz et al. · British Journal of Cancer · 2008 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer

Jon Kroll Bjerregaard, Michael Bau Mortensen, Helle Anita Jensen et al. · Radiotherapy and Oncology · 2009 · 16 citations

Medicine, Oncology, Radiation Oncology +9